Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
1.
Ocul Immunol Inflamm ; 31(1): 127-133, 2023 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-34784260

RESUMO

PURPOSE: To describe endogenous endophthalmitis in the setting of Covid-19 pneumonia post recovery. METHODS: Retrospective review of five patients of endogenous endophthalmitis following Covid-19 disease done. RESULTS: All five cases had received systemic corticosteroid for a mean duration of 7 days during severe Covid-19 treatment. Decrease vision was presenting symptom between 1 and 31 days following Covid-19 recovery. All patients had presumed fungal endogenous endophthalmitis based on clinical profile. Four out of five patients subjected to pars plana vitrectomy had microbiologically proven aspergillus species endogenous endophthalmitis on vitreous fluid assessment; two cases each of aspergillus niger and aspergillus fumigates. Four eyes underwent pars plana vitrectomy with silicone oil injection had shown satisfactory anatomical outcome with control of the infection; however, no significant visual gain achieved. CONCLUSION: We reported five cases of aspergillus endogenous endophthalmitis in Covid-19 recovered patients to document the likely presentation of this rising entity and avoid misdiagnosis.


Assuntos
Aspergilose , COVID-19 , Endoftalmite , Infecções Oculares Fúngicas , Humanos , Abscesso/diagnóstico , Abscesso/etiologia , Abscesso/tratamento farmacológico , Tratamento Farmacológico da COVID-19 , COVID-19/complicações , Aspergillus , Endoftalmite/diagnóstico , Endoftalmite/tratamento farmacológico , Endoftalmite/etiologia , Aspergilose/diagnóstico , Aspergilose/tratamento farmacológico , Aspergilose/microbiologia , Vitrectomia , Infecções Oculares Fúngicas/diagnóstico , Infecções Oculares Fúngicas/tratamento farmacológico , Infecções Oculares Fúngicas/microbiologia , Estudos Retrospectivos
3.
Indian J Ophthalmol ; 69(9): 2537-2539, 2021 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-34427263

RESUMO

Rhino-orbital-cerebral mucormycosis (ROCM) with intracranial extension is a fatal disease. A case of extensive ROCM, with rare intracranial fungal granuloma, seen in a COVID-19 positive young male is described. A successful therapy consisting of a multidisciplinary approach for sinuses debridement, orbital exenteration, and intracranial granuloma excision was done. Nonseptate hyphae of Mucor and septate filamentous Aspergillus grew concurrently from exenterated orbital specimen.


Assuntos
COVID-19 , Micoses , Doenças Orbitárias , Antifúngicos/uso terapêutico , Granuloma/diagnóstico , Granuloma/tratamento farmacológico , Humanos , Masculino , Doenças Orbitárias/diagnóstico , Doenças Orbitárias/tratamento farmacológico , Doenças Orbitárias/cirurgia , SARS-CoV-2
4.
BMJ Open Ophthalmol ; 6(1): e000558, 2021.
Artigo em Inglês | MEDLINE | ID: mdl-34395913

RESUMO

Proboscis lateralis (PL) is a rare congenital malformation of the craniofacial structure with varied clinical associations. None of the studies documented a discrete review of ophthalmic presentations in PL. The principal aim of the present study is to explore the ophthalmic manifestations of PL. The ancillary goal is to derive a relationship between congenital deformity in PL and various ophthalmic anomalies. Databases were searched in order to obtain articles related to PL. A qualitative systematic analysis of 100 subjects was performed. In PL, eyelid coloboma (32.6%) is the most common ocular feature, followed by hypertelorism (25.3%), iris coloboma (22.4%), lacrimal system abnormality (20.7%), malpositioned eyebrow (14.4%) and retinochoroidal coloboma (12.9%). Sinonasal deformity is the most common systemic abnormality, detected in 87.9% of cases of PL, as compared with central nervous system involvement (56.2%) and other anomalies. The analysis showed a strong significant association between brain abnormalities and hypertelorism (p=0.000) and between brain abnormalities and micro-ophthalmia/anophthalmia (p=0.000). Statistically significant association was noted between cumulative ocular abnormalities and cumulative systemic abnormalities (p=0.001). The present study on PL reviewed the salient features of this rare congenital disorder. The study outcome provides a new aspect to concomitant ocular abnormalities. This study supports the view that other congenital anomalies in cases of PL had significant influence on certain ophthalmic anomalies.

5.
Ocul Immunol Inflamm ; 26(5): 753-759, 2018.
Artigo em Inglês | MEDLINE | ID: mdl-27901644

RESUMO

PURPOSE: To determine the clinical features, treatment, and visual outcome in ocular toxocariasis. METHODS: A total of 16 cases diagnosed as ocular toxocariasis clinically and/or serologically were analyzed retrospectively. RESULTS: The mean age of the patients was 22.6 years. Cases were categorized into three clinical types with peripheral granuloma (43.7%) as the most common presentation. Of the patients, 10 (62.5%) had positive serum ELISA for T. canis; five (31.2%) received combination treatment with anthelmintic and corticosteroid, and eight (50%) patients had vitreous surgery. The visual outcome in eyes which underwent surgery was better, however the difference in medically and surgically treated groups was insignificant (p = 0.11). There was also no difference in visual outcome among the three clinical groups (p = 0.20). CONCLUSIONS: Ocular toxocariasis has a varied presentation spectrum. Serum ELISA for T. canis aids in diagnosis. The difference in visual outcome among clinical and treatment groups was insignificant. However, in general, ocular toxocariasis resulted in a poor visual outcome.


Assuntos
Anti-Helmínticos/uso terapêutico , Infecções Oculares Parasitárias/diagnóstico , Centros de Atenção Terciária , Toxocaríase/diagnóstico , Acuidade Visual , Adolescente , Adulto , Animais , Anticorpos Anti-Helmínticos/análise , Criança , Pré-Escolar , Ensaio de Imunoadsorção Enzimática , Infecções Oculares Parasitárias/tratamento farmacológico , Infecções Oculares Parasitárias/parasitologia , Feminino , Humanos , Índia/epidemiologia , Masculino , Pessoa de Meia-Idade , Estudos Retrospectivos , Toxocara/imunologia , Toxocaríase/tratamento farmacológico , Toxocaríase/parasitologia , Adulto Jovem
SELEÇÃO DE REFERÊNCIAS
Detalhe da pesquisa